Stockscreener 앱 받기
0.5891
0.82%
-0.0049
시간 외 거래:
.59
0.0009
+0.15%
전일 마감가:
$0.594
열려 있는:
$0.5842
하루 거래량:
371.45K
Relative Volume:
0.25
시가총액:
$242.32M
수익:
$306.91M
순이익/손실:
$-59.11M
주가수익비율:
-3.9273
EPS:
-0.15
순현금흐름:
$6.35M
1주 성능:
-3.80%
1개월 성능:
+3.42%
6개월 성능:
-9.09%
1년 성능:
-49.43%
1일 변동 폭
$0.576
$0.6039
1주일 범위
$0.5617
$0.6249
52주 변동 폭
$0.4303
$1.36
Amarin Corp Adr Stock (AMRN) Company Profile
명칭
Amarin Corp Adr
전화
353 1 6699 020
주소
SPACES SOUTH DOCKLANDS, BLOCK C, DUBLIN 2
AMRN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AMRN
Amarin Corp Adr
|
0.5891 | 242.32M | 306.91M | -59.11M | 6.35M | -0.15 |
|
LLY
Lilly Eli Co
|
873.68 | 830.35B | 45.04B | 10.59B | 414.30M | 11.71 |
|
NVO
Novo Nordisk Adr
|
88.08 | 390.99B | 42.09B | 14.65B | 10.11B | 3.2833 |
|
ABBV
Abbvie Inc
|
202.08 | 356.74B | 56.33B | 4.28B | 17.83B | 2.40 |
|
JNJ
Johnson Johnson
|
162.30 | 344.63B | 88.82B | 14.07B | 18.06B | 5.79 |
|
MRK
Merck Co Inc
|
89.50 | 251.88B | 64.17B | 17.12B | 14.84B | 6.7297 |
Amarin Corp Adr Stock (AMRN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-11-20 | 재개 | JP Morgan | Underweight |
| 2023-10-25 | 다운그레이드 | Jefferies | Buy → Hold |
| 2023-01-06 | 업그레이드 | Jefferies | Hold → Buy |
| 2022-05-06 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2022-05-05 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2022-05-05 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2022-05-04 | 다운그레이드 | Northland Capital | Outperform → Market Perform |
| 2021-05-12 | 다운그레이드 | Goldman | Neutral → Sell |
| 2020-09-29 | 재개 | JP Morgan | Neutral |
| 2020-08-26 | 개시 | Piper Sandler | Overweight |
| 2020-05-05 | 개시 | Northland Capital | Outperform |
| 2020-03-31 | 다운그레이드 | Goldman | Buy → Neutral |
| 2020-03-31 | 다운그레이드 | Jefferies | Buy → Hold |
| 2020-03-31 | 업그레이드 | Oppenheimer | Underperform → Perform |
| 2020-03-13 | 업그레이드 | Goldman | Neutral → Buy |
| 2020-03-02 | 개시 | Cowen | Outperform |
| 2020-02-18 | 업그레이드 | Citigroup | Neutral → Buy |
| 2020-01-06 | 개시 | JP Morgan | Neutral |
| 2019-12-16 | 다운그레이드 | Stifel | Buy → Hold |
| 2019-11-20 | 개시 | Oppenheimer | Underperform |
| 2019-11-18 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2019-11-15 | 재확인 | SVB Leerink | Outperform |
| 2019-10-31 | 개시 | Aegis Capital | Buy |
| 2019-10-15 | 개시 | Goldman | Neutral |
| 2019-08-14 | 개시 | SVB Leerink | Outperform |
| 2019-07-09 | 재확인 | Jefferies | Buy |
| 2019-06-17 | 개시 | ROTH Capital | Buy |
| 2019-03-22 | 개시 | Stifel | Buy |
모두보기
Amarin Corp Adr 주식(AMRN)의 최신 뉴스
Amarin Corp ADR (AMRN) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - SETE News
European Equities Traded in the US as American Depositary Receipts Tread Water in Wednesday Trading - TradingView
Amarin Corp ADR [AMRN] Stock bought by Insider Berg Aaron for $0.1 million - Knox Daily
Ratios Uncovered: Breaking Down Amarin Corp ADR (AMRN)’s Trailing Twelve Months Metrics - The Dwinnex
Checking in on Indivior Plc (INDV) after recent insiders movement - Knox Daily
Ratios Uncovered: Breaking Down Neuronetics Inc (STIM)’s Trailing Twelve Months Metrics - The Dwinnex
Are Smart Investors Making the Right Decision? Amarin Corp ADR (AMRN) - SETE News
Views of Wall Street’s Leading Experts on SciSparc Ltd - SETE News
Stocks of Talen Energy Corp (TLN) are poised to climb above their peers - SETE News
Scholar Rock Holding Corp (SRRK) requires closer examination - US Post News
Amarin Corp ADR (AMRN) shows promising results - US Post News
Analysts review Amarin Corp ADR’s rating - Knox Daily
ALLY’s latest rating updates from top analysts. - Knox Daily
Ratio Review: Analyzing Caleres Inc (CAL)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
Financial Health Report: Tevogen Bio Holdings Inc (TVGN)’s Ratios Tell a Tale - The Dwinnex
Financial Metrics Exploration: Understanding Opendoor Technologies Inc (OPEN) Through Ratios - The Dwinnex
Potential Price Increase for Godaddy Inc (GDDY) After Recent Insider Activity - Knox Daily
Analyzing Ratios: Amarin Corp ADR (AMRN)’s Financial Story Unveiled - The Dwinnex
Establishment Labs Holdings Inc (ESTA) expanding its growth trajectory ahead - SETE News
European Equities Traded in the US as American Depositary Receipts Higher in Thursday Trading - MSN
Amarin stock touches 52-week low at $0.45 amid challenges - Investing.com
Italy grants VAZKEPA reimbursement for heart risk - Investing.com
Amarin Corporation plc (ADR) : Amarin Announces Market Introduction of Vascepa(R) (icosapent ethyl) Capsules for the Treatment of Very High Triglycerides (VHTG) - Marketscreener.com
Amarin appoints new chief financial officer - Investing.com
Amarin Appoints Peter Fishman Chief Financial Officer - GlobeNewswire Inc.
Amarin stock plunges to 52-week low of $0.46 amid challenges - Investing.com
Amarin granted extension to meet Nasdaq listing standards - Investing.com
European Equities Traded in the US as American Depositary Rise in Monday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading - MSN
European Equities Traded in the US as American Depositary Move Higher in Monday Trading - MSN
After Plunging -19.13% in 4 Weeks, Here's Why the Trend Might Reverse for Amarin (AMRN) - Yahoo Finance
Top 3 Health Care Stocks You'll Regret Missing In Q4 - Benzinga
Amarin stock touches 52-week low at $0.55 amid market challenges - Investing.com
European Equities Traded in the US as American Depositary Receipts Close Bearish Week on High Note Friday - MSN
A Must-See Look at Amarin's Best- and Worst-Case Scenarios - AOL
Amarin's Q3 Earnings In Line, Revenues Fall Shy Of Estimates - Barchart
Earnings call: Amarin reports Q3 revenue dip amid U.S. generic competition - Investing.com
Amarin Plc (AMRN) Q3 2024 Earnings Call Transcript - AOL
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading - MSN
Amarin stock plunges to 52-week low of $0.56 amid market challenges - Investing.com India
European Equities Traded in the US as American Depositary Receipts Decline Tuesday - MSN
European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading - MSN
Amarin Corp ADR [AMRN] Investment Guide: What You Need to Know - Knox Daily
The growth track for Amarin Corp ADR (AMRN) has changed recently - SETE News
BofA Securities downgrades Agilon Health Inc (AGL) stock to an Underperform - Knox Daily
Amarin Corp ADR (AMRN) requires closer examination - US Post News
Investing in Amarin Corp ADR (AMRN): What You Must Know - Knox Daily
Take off with Amarin Corp ADR (AMRN): Get ready for trading - SETE News
Keeping an Eye on Bicycle Therapeutics Plc ADR (BCYC) After Insider Trading Activity - Knox Daily
Capital One Financial Corp.’s latest rating changes from various analysts - Knox Daily
Opthea expands leadership team amid clinical trials - Investing.com
Amarin Corp Adr (AMRN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.61%
0.07%
자본화:
|
볼륨(24시간):